Guangdong Zhongsheng Pharmaceutical Co Ltd (002317) — Free Cash Flow Generation Index
Guangdong Zhongsheng Pharmaceutical Co Ltd (002317) has a Free Cash Flow Generation Index of 0.07x as of September 2025. Free cash flow of CN¥5.81 Million represents 0% of operating cash flow (CN¥88.00 Million). Read total liabilities of Guangdong Zhongsheng Pharmaceutical Co L for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Guangdong Zhongsheng Pharmaceutical Co Ltd Free Cash Flow Generation Index (2006–2024)
Historical FCF Generation Index trend for Guangdong Zhongsheng Pharmaceutical Co Ltd across 19 annual periods. Explore how much does Guangdong Zhongsheng Pharmaceutical Co L reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Guangdong Zhongsheng Pharmaceutical Co Ltd (2006–2024)
Year-by-year Free Cash Flow Generation Index for Guangdong Zhongsheng Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see 002317 market cap overview.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.32x | CN¥109.58 Million | CN¥337.84 Million | CN¥228.26 Million | ▲ +135.9% |
| 2023 | -0.90x | CN¥-172.44 Million | CN¥190.61 Million | CN¥363.06 Million | ▲ +72.2% |
| 2022 | -3.25x | CN¥-204.89 Million | CN¥63.07 Million | CN¥267.96 Million | ▼ -594.7% |
| 2021 | 0.66x | CN¥409.00 Million | CN¥622.77 Million | CN¥213.76 Million | ▲ +688.6% |
| 2020 | -0.11x | CN¥-15.50 Million | CN¥138.93 Million | CN¥154.43 Million | ▼ -122.8% |
| 2019 | 0.49x | CN¥122.83 Million | CN¥251.16 Million | CN¥128.33 Million | ▼ -12.8% |
| 2018 | 0.56x | CN¥183.31 Million | CN¥326.78 Million | CN¥143.48 Million | ▼ -15.5% |
| 2017 | 0.66x | CN¥245.62 Million | CN¥369.91 Million | CN¥124.28 Million | ▲ +14.0% |
| 2016 | 0.58x | CN¥197.10 Million | CN¥338.28 Million | CN¥141.19 Million | ▼ -3.2% |
| 2015 | 0.60x | CN¥115.68 Million | CN¥192.25 Million | CN¥76.57 Million | ▲ +161.2% |
| 2014 | -0.98x | CN¥-98.95 Million | CN¥100.60 Million | CN¥199.54 Million | ▼ -11243.5% |
| 2013 | -0.01x | CN¥-962.04K | CN¥110.95 Million | CN¥111.91 Million | ▼ -101.9% |
| 2012 | 0.46x | CN¥64.96 Million | CN¥142.38 Million | CN¥77.42 Million | ▲ +128.0% |
| 2011 | -1.63x | CN¥-114.85 Million | CN¥70.56 Million | CN¥185.41 Million | ▼ -704.5% |
| 2010 | 0.27x | CN¥24.70 Million | CN¥91.72 Million | CN¥67.02 Million | ▼ -65.2% |
| 2009 | 0.77x | CN¥78.06 Million | CN¥100.89 Million | CN¥22.83 Million | ▲ +5.6% |
| 2008 | 0.73x | CN¥53.37 Million | CN¥72.86 Million | CN¥19.49 Million | ▲ +52.6% |
| 2007 | 0.48x | CN¥23.69 Million | CN¥49.35 Million | CN¥25.67 Million | ▲ +6.5% |
| 2006 | 0.45x | CN¥8.07 Million | CN¥17.91 Million | CN¥9.84 Million | — |